Warning letter
Cascadia Manufacturing, Inc.: warning letter of Aug 6, 2008
FDA warning letter UCM1048190 · Seattle District Office
Key facts
| Reference number | UCM1048190 |
|---|---|
| Company | Cascadia Manufacturing, Inc. |
| Subject | CGMP For Manfacturing, Processing, Packing, Storage & Holding/Adulterated |
| Issue date | Aug 6, 2008 |
| Posted date | Aug 6, 2008 |
| Issuing office | Seattle District Office |
| Product type | Drugs |
| CFR sections cited | 211.63, 211.87, 211.166, 211.188, 211.192, 211.22(d), 211.67(a), 211.67(b), 211.68(a), 211.84(d)(1), 211.84(d)(6), 211.100(b) and 10 more |
| Country | 3 |
| Inspection city | Bellevue |
| Inspection ZIP | 98005-4211 |
| Inspection start date | Jan 31, 2008 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: